GINGIVAL OVERGROWTH: ROLE OF PHENYTOIN METABOLITES
牙龈过度生长:苯妥英代谢物的作用
基本信息
- 批准号:3220068
- 负责人:
- 金额:$ 10.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1983
- 资助国家:美国
- 起止时间:1983-04-01 至 1989-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Epileptics on chronic phenytoin (PHT, 5,5-diphenylhydantoin) therapy
frequently experience a toxic reaction to the drug, PHT-induced gingival
overgrowth (GO), in approximately 50% of the population. The lesion is
characterized by an increase in the connective tissue substance of the
gingivae, which is postulated to occur by stimulation of gingival
fibroblasts by PHT and its metabolites. The lesion also predisposes
"responders" to the drug to an increased likelihood of gingival
inflammation and infection. The proposed studies will examine pediatric
epileptic patients on PHT therapy and attempt to correlate drug metabolism
parameters with the incidence and severity of gingival overgrowth. The
theory that the presence of enzyme-inducing co-medications increases the
incidence of GO will be examined. Gas chromatographic and high-pressure
liquid chromatographic (HPLC) methods will be used to assay the number,
types, and stereochemistry of PHT metabolites, particularly the phenolic
(p-HPPH) and dihydrodiol (DHD) metabolites, as these are derived from
potentially toxic arene oxide intermediates. Temporal changes in gingival
overgrowth and PHT metabolism will be studied as patients progress in the
study. A second portion of the study will examine the cytotoxic or
mitogenic effects of p-HPPH and DHD stereoisomers on cultured human
gingival fibroblasts in vitro. Metabolism of 14C-PHT by gingival
fibroblasts will be examined with the use of HPLC techniques. The gingival
fibroblast studies will provide additional information as to how PHT
metabolites, generated in situ by fibroblast metabolism of PHT, or absorbed
from the blood stream, exert their effects to cause a proliferation similar
to that observed in vivo. The pediatric study will provide PHT metabolism
data in responders and non-responders and will attempt to correlate
differences in susceptibility to the actions of PHT metabolites in vitro.
0f the pediatric study confirms the increased incidence of gingival
overgrowth with enzyme-inducing antiepileptic co-medication,
recommendations for antiepileptic therapies utilizing PHT could be made
such that a lower incidence of GO would result.
慢性苯妥英(PHT, 5,5-二苯妥英)治疗癫痫
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES H MAGUIRE其他文献
JAMES H MAGUIRE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES H MAGUIRE', 18)}}的其他基金
GINGIVAL OVERGROWTH: ROLE OF PHENYTOIN METABOLITES
牙龈过度生长:苯妥英代谢物的作用
- 批准号:
3220069 - 财政年份:1983
- 资助金额:
$ 10.1万 - 项目类别:
GINGIVAL OVERGROWTH: ROLE OF PHENYTOIN METABOLITES
牙龈过度生长:苯妥英代谢物的作用
- 批准号:
3220070 - 财政年份:1983
- 资助金额:
$ 10.1万 - 项目类别: